139 related articles for article (PubMed ID: 10882145)
1. Metabolic effects of fluoxetine in obese menopausal women.
Bondi M; Menozzi R; Bertolini M; Venneri MG; Del Rio G
J Endocrinol Invest; 2000 May; 23(5):280-6. PubMed ID: 10882145
[TBL] [Abstract][Full Text] [Related]
2. Effect of a novel beta-adrenoceptor agonist (Ro 40-2148) on resting energy expenditure in obese women.
Haesler E; Golay A; Güzelhan C; Schutz Y; Hartmann D; Jéquier E; Felber JP
Int J Obes Relat Metab Disord; 1994 May; 18(5):313-22. PubMed ID: 7914795
[TBL] [Abstract][Full Text] [Related]
3. The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects: a double-blind placebo-controlled study.
Scalfi L; D'Arrigo E; Carandente V; Coltorti A; Contaldo F
Int J Obes Relat Metab Disord; 1993 Feb; 17(2):91-6. PubMed ID: 8384170
[TBL] [Abstract][Full Text] [Related]
4. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females.
Walsh KM; Leen E; Lean ME
Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1009-15. PubMed ID: 10557020
[TBL] [Abstract][Full Text] [Related]
5. Effects of dexfenfluramine on resting metabolic rate and thermogenesis in premenopausal obese women during therapeutic weight reduction.
Van Gaal LF; Vansant GA; Steijaert MC; De Leeuw IH
Metabolism; 1995 Feb; 44(2 Suppl 2):42-5. PubMed ID: 7869937
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the thermogenic effects of fluoxetine in obese subjects.
Stinson JC; Murphy CM; Andrews JF; Tomkin GH
Int J Obes Relat Metab Disord; 1992 May; 16(5):391-5. PubMed ID: 1319975
[TBL] [Abstract][Full Text] [Related]
7. Effect of impaired glucose tolerance and type II diabetes on resting metabolic rate and thermic response to a glucose meal in obese women.
Nair KS; Webster J; Garrow JS
Metabolism; 1986 Jul; 35(7):640-4. PubMed ID: 3523118
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine increases resting energy expenditure and basal body temperature in humans.
Bross R; Hoffer LJ
Am J Clin Nutr; 1995 May; 61(5):1020-5. PubMed ID: 7733022
[TBL] [Abstract][Full Text] [Related]
9. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
Due A; Flint A; Eriksen G; Møller B; Raben A; Hansen JB; Astrup A
Diabetes Obes Metab; 2007 Jul; 9(4):566-74. PubMed ID: 17587399
[TBL] [Abstract][Full Text] [Related]
10. Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Ravussin E; Bogardus C; Schwartz RS; Robbins DC; Wolfe RR; Horton ES; Danforth E; Sims EA
J Clin Invest; 1983 Sep; 72(3):893-902. PubMed ID: 6350368
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.
Gougeon R
Obes Res; 2001 Apr; 9(4):241-50. PubMed ID: 11331427
[TBL] [Abstract][Full Text] [Related]
12. The role of energy expenditure in the differential weight loss in obese women on low-fat and low-carbohydrate diets.
Brehm BJ; Spang SE; Lattin BL; Seeley RJ; Daniels SR; D'Alessio DA
J Clin Endocrinol Metab; 2005 Mar; 90(3):1475-82. PubMed ID: 15598683
[TBL] [Abstract][Full Text] [Related]
13. Thermogenic effects of sibutramine in humans.
Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
Am J Clin Nutr; 1998 Dec; 68(6):1180-6. PubMed ID: 9846844
[TBL] [Abstract][Full Text] [Related]
14. Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men.
Larsen TM; Toubro S; van Baak MA; Gottesdiener KM; Larson P; Saris WH; Astrup A
Am J Clin Nutr; 2002 Oct; 76(4):780-8. PubMed ID: 12324291
[TBL] [Abstract][Full Text] [Related]
15. Evolution of glucose induced thermogenesis in obese subjects with and without diabetes: a six-year follow-up study.
Golay A; Jallut D; Schutz Y; Felber JP; Jéquier E
Int J Obes; 1991 Sep; 15(9):601-7. PubMed ID: 1960011
[TBL] [Abstract][Full Text] [Related]
16. Influence of age on the thermic response to caffeine in women.
Arciero PJ; Bougopoulos CL; Nindl BC; Benowitz NL
Metabolism; 2000 Jan; 49(1):101-7. PubMed ID: 10647072
[TBL] [Abstract][Full Text] [Related]
17. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
18. Effect of weight reduction on resting energy expenditure, substrate utilization, and the thermic effect of food in moderately obese women.
Nelson KM; Weinsier RL; James LD; Darnell B; Hunter G; Long CL
Am J Clin Nutr; 1992 May; 55(5):924-33. PubMed ID: 1570799
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic blockade and intravenous nutrient-induced thermogenesis in lean and obese women.
Vernet O; Nacht CA; Christin L; Schutz Y; Danforth E; Jequier E
Am J Physiol; 1987 Jul; 253(1 Pt 1):E65-71. PubMed ID: 2886053
[TBL] [Abstract][Full Text] [Related]
20. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
